Results 91 to 100 of about 65,545 (257)

Bruton tyrosine kinase inhibitors and cardiovascular adverse events

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Bruton tyrosine kinase inhibitors (BTKi) have transformed the management of chronic lymphocytic leukaemia and other B‐cell malignancies, yet their therapeutic benefit is tempered by clinically relevant cardiovascular toxicities (predominantly atrial fibrillation, hypertension, bleeding and ventricular arrhythmias).
Massimiliano Camilli   +4 more
wiley   +1 more source

Cisterna Chyli Dilation Is a Risk Factor for Liver Nodules and Hepatocellular Carcinoma in Fontan‐Associated Liver Disease: Pathophysiological Role of Lymphatic Dysfunction

open access: yesHepatology Research, EarlyView.
ABSTRACT Aim In Fontan‐associated liver disease (FALD), chronic congestion often confounds conventional fibrosis markers, complicating surveillance for hepatocellular carcinoma (HCC). Although lymphatic dysfunction is fundamental to Fontan physiology, its contribution to hepatocarcinogenesis remains unclear.
Koji Imoto   +14 more
wiley   +1 more source

Do We Really Know How to Manage Anticoagulated Patients for Periodontal Nonsurgical Therapy? An Observational Cohort Study

open access: yesInternational Journal of Dental Hygiene, EarlyView.
ABSTRACT Objectives The aim of this work is to assess and compare the impact of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKA) during and immediately after periodontal nonsurgical therapy. Materials and Methods A prospective observational cohort study was conducted with patients who presented a history of cardiovascular disease ...
F. Berton   +5 more
wiley   +1 more source

Projected health‐service cost impact of dalbavancin consolidation therapy for Staphylococcus aureus bacteraemia in an Australian public health system

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background Management of Staphylococcus aureus bacteraemia (SAB) requires prolonged intravenous (IV) antibiotic therapy delivered in hospital or through Hospital in the Home (HITH), often requiring peripherally inserted central catheters (PICCs) and substantial healthcare resources.
Eli Dunn   +3 more
wiley   +1 more source

Catheter Ablation: Evolution and Efficiencies

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT The present review includes a discussion the goals and pitfalls of efficiency in the medical profession, a historical perspective on the evolution of catheter ablation in the field of electrophysiology (EP), and the data regarding the relationship between efficiency and outcomes in the EP lab. Focus on efficacy is critical to maximize resource
Aravind G. Kalluri, Bradley P. Knight
wiley   +1 more source

Oral Anticoagulation Therapy Increased the Incidence of Abnormal Uterine Bleeding in Patients with Thrombophilia: A Single-center Retrospective Study

open access: yesXiehe Yixue Zazhi
Objective  To investigate the incidence and adverse effects of abnormal uterine bleeding (AUB) during oral anticoagulation therapy in women with thrombophilia.
ZHANG Wenjing, ZHU Tienan, LI Kuixing
doaj   +1 more source

Evolving Mechanisms on Mortality in Atrial Fibrillation: A 25‐Year National Death‐Certificate Analysis

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
This 25‐year national analysis reveals a major shift in atrial fibrillation‐related mortality, driven by rapidly rising rates of heart failure and stroke‐free dementia. These trends underscore the urgent need to expand management beyond traditional stroke prevention to prioritize comprehensive heart failure care and cognitive health.
Jacqueline S. Dickey   +11 more
wiley   +1 more source

Anticoagulation in Patients With Device‐Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH‐AFNET 6 Trial

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Short and rare episodes of atrial fibrillation (AF) are commonly detected using implanted devices (device‐detected AF) in patients with prior stroke or transient ischemic attack (TIA).
Hans Christoph Diener   +33 more
doaj   +1 more source

Contemporary Outcomes of Catheter Ablation of Long‐Standing Persistent Atrial Fibrillation

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Advances in mapping and ablation have improved the safety and efficacy of catheter‐based ablation (CA) of atrial fibrillation (AF). Patients with long‐standing persistent atrial fibrillation (LSPAF) historically have poor ablation outcomes; however, they are underrepresented in contemporary reports.
Dakota De Cecco   +15 more
wiley   +1 more source

Variation in Anticoagulation Practice for Atrial High‐Rate Episodes: A Nationwide Cross‐Sectional Survey

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Atrial high‐rate episodes (AHRE) detected by cardiac implantable electronic devices (CIEDs) are associated with increased thromboembolic risk, yet their clinical significance and optimal anticoagulation strategy remain uncertain, particularly in the absence of electrocardiogram (ECG)‐confirmed atrial fibrillation.
Kyi Zin Thant   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy